Purpose-led, performance-driven

Royal DSM is a global, purpose-led company in health and nutrition, applying science to improve the health of people, animals, and the planet. DSM’s purpose is to create brighter lives for all which we achieve through developing products and solutions that address some of the world’s biggest challenges while simultaneously creating economic, environmental, and societal value for all its stakeholders – customers, employees, shareholders, and society-at-large.

DSM at a glance

Key facts and figures about DSM, our broad, global health and nutrition business, and our people, planet and profit performance.
 

Results center

We routinely publish our financial performance, with more detail at half and full year where we also provide updates on key milestones on our strategic journey.
 

Share center

DSM has celebrated more than three decades since its privatisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.

Headlines (continuing operations) 2021

€9,204m

Net sales

€8,106m in 2020

€1,814m

Adjusted EBITDA

€1,534m in 2020

19.7%

Adjusted EBITDA margin

18.9% in 2020

Health, Nutrition & Bioscience

 

DSM’s continuing operations are organized around three business groups, each with clear opportunities to benefit the health of people and the health of the planet which underpin DSM’s growth plans.

Food & Beverage (F&B) combines food, beverage, and pet food activities. This business group is uniquely able to meet the needs of customers and consumers by developing sustainable taste, texture, and health solutions. The business group’s portfolio includes breakthrough innovations such as EVERSWEET™, a natural calorie-free sweetener, and CanolaPRO®, a plant-based alternative protein.

Health, Nutrition & Care (HNC) aims to keep the world’s growing population healthy through nutrition and care. This business group provides unique, sustainable, science-based and innovative solutions for consumers in early-life nutrition, dietary supplements, pharma, medical nutrition, personal care, fragrances, and biomedical materials, as well as nutrition improvement for the most vulnerable communities. It includes a rich innovation portfolio including ampli-D®, the rapid-acting and potent form of vitamin D, an extensive algal lipids portfolio, personalized nutrition initiatives such as Hologram Sciences™, as well as human milk oligosaccharide-prebiotics.

Animal Nutrition & Health (ANH) focuses on specialty solutions for a radical transformation in the sustainability of animal protein production. Incorporating essential products such as vitamins, carotenoids, eubiotics and mycotoxin risk management, as well as a wide range of impactful innovations such as methane inhibitor Bovaer® and fish-oil algae-alternative Veramaris®. This business group also includes precision initiatives with data-driven decision-making tools for famers like Sustell™, and for veterinarians and animal health practitioners like Verax™.

€7,166m

Net Sales

€1,467m

Adjusted EBITDA

20.5%

Adjusted EBITDA margin

€3,347m

Animal Nutrition & Health

€2,516m

Health Nutrition & Care

€1,256m

Food & Beverage

>€1bn

of sales

came from immunity-optimizing ingredients in 2021

>55

Animal nutrition premix facilities

& 15 human nutrition premix facilities

70%

reduction in land use

with EVERSWEET™ stevia sweetener compared to bio-converted Reb M

Latest financial & regulatory news

Read more

  • DSM at a glance

    DSM at a glance

    Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.

  • Financial results & presentations

    Financial results & presentations

    Instant overview of the financial results, presentations, updates & AGMs and all DSM's financial and regulatory press releases from the last decade.